home / scout

Targets — browse / sort / filter (view)

One row per human protein target with names + key evidence. Click column headers to SORT; use the facets to FILTER (tier, activation pair, known aptamer, EV-Map). UniProt IDs link to the source. Default sort is evidence_priority — a DETERMINISTIC, reproducible score computed from harvested evidence (structure / disease / predicted-surface / EV-detection). Filter has_structure=1 for the core set: targets with a reported 3D structure (the requirement the Kd layer is built around).

Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target

id
UniProt accession (human). Links to uniprot.org.
gene_symbol
Gene symbol (e.g. ITGB3).
protein_name
Protein name (UniProt).
tier
Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
has_structure
1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
evidence_priority
DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
has_activation_state_pdb_pair
1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
in_cev_map
Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
has_known_aptamer
1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
opentargets_top_disease_score
Open Targets association score (0-1).
aptamer_count_pubmed
Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
aptamer_pmids
The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
surface_class
PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.

144 rows where has_known_aptamer = 1, in_cev_map = 0 and surface_class = "A_surface" sorted by evidence_priority descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: aptamer_count_pubmed

tier 2

  • Tier 1 82
  • Tier 1.5 62

has_structure 2

  • 1 127
  • 0 17

has_cryoEM 2

  • 0 84
  • 1 60

surface_class 1

  • A_surface · 144 ✖

in_cev_map 1

  • - · 144 ✖

has_known_aptamer 1

  • 1 · 144 ✖

has_activation_state_pdb_pair 1

  • 0 144
id gene_symbol protein_name tier evidence_priority ▲ has_structure surface_class pdb_count_total alphafold_mean_pLDDT has_cryoEM has_activation_state_pdb_pair activation_state_pdb_active activation_state_pdb_inactive has_known_aptamer aptamer_count_pubmed aptamer_pmids in_cev_map opentargets_top_disease_name opentargets_top_disease_score
P13569 CFTR Cystic fibrosis transmembrane conductance regulator Tier 1 0.824 1 A_surface 58 75.62 1 0     1 10 41148207, 31029337, 30595527, 22483890, 15657417 0 cystic fibrosis 0.9133535862571094
P07949 RET Proto-oncogene tyrosine-protein kinase receptor Ret Tier 1 0.809 1 A_surface 34 78.81 1 0     1 83 41962371, 41744190, 41636718, 41526122, 41406741, 41171123, 41082837, 41060784, 41027166, 40932619, 40815127, 40711581, 40633058, 40602121, 40410423, 40285964, 40252505, 40222299, 39344894, 39288589, 39190775, 38953438, 38876068, 38852325, 38718747, 38604287, 38354543, 38282384, 38237282, 37851382, 37774402, 37757695, 37437453, 37245460, 36952259, 36315022, 35550937, 35420408, 34342436, 34132907, 34016094, 33513536, 33462661, 33119785, 33011620, 32760976, 32527800, 32212604, 32138930, 31897454 0 medullary thyroid gland carcinoma 0.8617460262224842
Q12809 KCNH2 Voltage-gated inwardly rectifying potassium channel KCNH2 Tier 1 0.806 1 A_surface 23 62.75 1 0     1 1 22617876 0 Romano-Ward syndrome 0.8549238933917284
P31785 IL2RG Cytokine receptor common subunit gamma Tier 1.5 0.804 1 A_surface 14 75.5 1 0     1 2 30800133, 33869115 0 gamma chain deficiency 0.8469997000418428
P08100 RHO Rhodopsin Tier 1.5 0.804 1 A_surface 4 88.75 1 0     1 45 41963275, 41924874, 41636061, 40808302, 40642289, 40330320, 40045571, 39863313, 39788632, 38070612, 37191882, 36705086, 36696850, 36095194, 36049339, 35622174, 34709779, 34471566, 32696702, 32479610, 32319623, 32119944, 31737572, 31588238, 31535128, 29570714, 29281176, 28648779, 27893356, 25645980, 23757206, 23701883, 25033804, 22689339, 22302221, 22121695, 19766091, 19389625, 16419035, 12123800, 8743323, 7678562, 19188685, 18230760 0 retinitis pigmentosa 0.8481942240861982
P07911 UMOD Uromodulin Tier 1 0.803 1 A_surface 10 82.94 1 0     1 4 37533140, 35446786 0 familial juvenile hyperuricemic nephropathy type 1 0.8446536377993564
P07333 CSF1R Macrophage colony-stimulating factor 1 receptor Tier 1 0.802 1 A_surface 26 77.81 0 0     1 1 29277631 0 leukoencephalopathy, diffuse hereditary, with spheroids 1 0.8391971566583056
O95342 ABCB11 Bile salt export pump Tier 1.5 0.801 1 A_surface 8 83.12 1 0     1 1 36313979 0 progressive familial intrahepatic cholestasis type 2 0.8372060401943777
P42262 GRIA2 Glutamate receptor 2 Tier 1 0.8 1 A_surface 16 84.94 0 0     1 4 28325839, 19417060, 17929944, 17024188 0 neurodevelopmental disorder with language impairment and behavioral abnormalities 0.8328652004757138
P16473 TSHR Thyrotropin receptor Tier 1 0.8 1 A_surface 9 74.0 1 0     1 6 41054857, 40997970, 40588369, 38650837 0 hypothyroidism due to TSH receptor mutations 0.8327127196409464
Q92736 RYR2 Ryanodine receptor 2 Tier 1 0.8 1 A_surface 26   1 0     1 1 24130701 0 catecholaminergic polymorphic ventricular tachycardia 1 0.8338648743498255
P10912 GHR Growth hormone receptor Tier 1.5 0.799 1 A_surface 9 58.69 0 0     1 5 38811951, 38477735, 31603904 0 Laron syndrome 0.8304020079647765
Q9ULV1 FZD4 Frizzled-4 Tier 1 0.795 1 A_surface 11 84.31 1 0     1 1 18673242 0 Familial exudative vitreoretinopathy 0.8152111103672746
Q13651 IL10RA Interleukin-10 receptor subunit alpha Tier 1 0.795 1 A_surface 7 62.0 1 0     1 2 25870409, 25558474 0 Autosomal recessive early-onset inflammatory bowel disease 0.8151052076044897
Q01974 ROR2 Tyrosine-protein kinase transmembrane receptor ROR2 Tier 1 0.794 1 A_surface 6 68.31 0 0     1 2 41782379, 18673242 0 autosomal recessive Robinow syndrome 0.8145559265435566
Q9UM73 ALK ALK tyrosine kinase receptor Tier 1 0.791 1 A_surface 79 68.19 0 0     1 6 40347134, 38604287, 32218299, 29205808, 24116381, 21281497 0 neuroblastoma 0.8016889264946979
Q4KMG0 CDON Cell adhesion molecule-related/down-regulated by oncogenes Tier 1 0.79 1 A_surface 3 62.03 0 0     1 3 36333824, 24629635, 18698484 0 holoprosencephaly 0.800378039564866
P16410 CTLA4 Cytotoxic T-lymphocyte protein 4 Tier 1.5 0.787 1 A_surface 22 80.12 0 0     1 26 41907643, 40972397, 40870970, 40811947, 40536609, 39417693, 38473398, 38158454, 36966395, 36831533, 36603108, 36015348, 33970170, 32929022, 32840510, 32280743, 32024070, 31405808, 28918052, 28082399, 26030229, 25565435, 24892807, 23460536, 23460531, 14612549 0 autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency 0.7906408646569979
P22223 CDH3 Cadherin-3 Tier 1 0.786 1 A_surface 19 76.75 0 0     1 1 41304780 0 EEM syndrome 0.7851776755128059
Q96MS0 ROBO3 Roundabout homolog 3 Tier 1.5 0.784 1 A_surface 3 63.69 0 0     1 2 32369590 0 horizontal gaze palsy with progressive scoliosis 0.7813306356858872
P43220 GLP1R Glucagon-like peptide 1 receptor Tier 1 0.78 1 A_surface 70 81.5 1 0     1 2 40691365, 30957581 0 type 2 diabetes mellitus 0.7667004144705459
P51654 GPC3 Glypican-3 Tier 1.5 0.779 1 A_surface 4 75.06 1 0     1 65 42083729, 41790019, 41653459, 41045695, 40825648, 40722645, 39998646, 39874791, 39608318, 39427046, 38910291, 38787447, 38621313, 38368644, 37665421, 36903516, 36457288, 36317566, 36072763, 35788872, 35699181, 35477501, 35051745, 34974867, 34306031, 33254049, 33080969, 32356075, 30347351, 30122918, 29675356, 29605994, 29277631, 27601357, 28263753 0 Simpson-Golabi-Behmel syndrome type 1 0.762708583613362
P20023 CR2 Complement receptor type 2 Tier 1.5 0.776 1 A_surface 9 74.94 1 0     1 1 33235290 0 immunodeficiency, common variable, 7 0.7543125403898414
P26678 PLN Phospholamban Tier 1 0.775 1 A_surface 7 81.88 0 0     1 9 39536855, 32382487, 30777430, 25240642, 21848510, 19158349 0 hypertrophic cardiomyopathy 0.750557685745381
Q9HBE5 IL21R Interleukin-21 receptor Tier 1 0.775 1 A_surface 6 64.12 0 0     1 2 30800133, 29244152 0 Cryptosporidiosis - chronic cholangitis - liver disease 0.7501392499286187
Q9Y6Q6 TNFRSF11A Tumor necrosis factor receptor superfamily member 11A Tier 1 0.775 1 A_surface 1 58.91 0 0     1 1 15562003 0 Osteopetrosis - hypogammaglobulinemia 0.7487328542164448
P04035 HMGCR 3-hydroxy-3-methylglutaryl-coenzyme A reductase Tier 1 0.774 1 A_surface 24 75.31 1 0     1 1 36470581 0 Hypercholesterolemia 0.7460937406970991
P40126 DCT L-dopachrome tautomerase Tier 1.5 0.774 1 A_surface 1 89.12 0 0     1 1 27245069 0 oculocutaneous albinism type 8 0.7468868816172217
P51681 CCR5 C-C chemokine receptor type 5 Tier 1 0.773 1 A_surface 25 85.38 1 0     1 23 36576612, 33981364, 29678881, 29556342, 29301363, 27807347, 27652575, 26965267, 25794434, 25754473, 25329893, 23629001, 22811524, 21576818, 18799178, 16631118, 16227301, 15813986, 14610191, 12498773 0 HIV infection 0.7442590579227027
Q9NR97 TLR8 Toll-like receptor 8 Tier 1 0.771 1 A_surface 39 86.12 0 0     1 4 40085160, 39956743 0 immunodeficiency 98 with autoinflammation, X-linked 0.7360623201088097
P21860 ERBB3 Receptor tyrosine-protein kinase erbB-3 Tier 1 0.77 1 A_surface 23 72.44 1 0     1 9 40851486, 33770580, 33039492, 31846731, 31626948, 29440899, 23990977, 22733765, 18942860 0 visceral neuropathy, familial, 1, autosomal recessive 0.7335342096528644
P08887 IL6R Interleukin-6 receptor subunit alpha Tier 1.5 0.768 1 A_surface 10 77.88 1 0     1 18 40853309, 38152968, 37034659, 36579647, 35890412, 33590853, 33340765, 32515246, 29211023, 28929152, 26552813, 26383776, 24481022, 24440854, 23235494, 22503683, 22258147, 22094809 0 rheumatoid arthritis 0.7269057706798291
Q00975 CACNA1B Voltage-dependent N-type calcium channel subunit alpha-1B Tier 1.5 0.767 1 A_surface 7 59.91 1 0     1 2 31118475, 25782368 0 Seizure 0.7217241968702018
P47871 GCGR Glucagon receptor Tier 1 0.766 1 A_surface 27 81.88 1 0     1 5 28775305, 23770039, 23744070 0 GCGR-related hyperglucagonemia 0.7213152740071143
P26842 CD27 CD27 antigen Tier 1 0.763 1 A_surface 5 71.69 0 0     1 3 39841045, 30609550, 26320067 0 lymphoproliferative syndrome 2 0.7084378623696481
P40225 THPO Thrombopoietin Tier 1 0.761 1 A_surface 3 61.44 1 0     1 2 38928037, 30312735 0 thrombocythemia 1 0.7027329039559379
P15941 MUC1 Mucin-1 Tier 1 0.761 1 A_surface 23 47.41 0 0     1 686 42025056, 41988862, 41954302, 41771296, 41744704, 41744190, 41657320, 41627316, 41621292, 41582516, 41535857, 41471303, 41362016, 41352919, 41346179, 41330302, 41243570, 41205458, 41185018, 41101154, 41047832, 41027169, 40682599, 40665615, 40627939, 40607530, 40590839, 40578633, 40568899, 40556592, 40504676, 40500890, 40499867, 40479828, 40432219, 40422041, 40360093, 40286646, 40274149, 40158809, 40119836, 39978149, 39910821, 39705316, 39679901, 39626346, 39579679, 39566700, 39552005, 39550818, 41997681, 41247195, 40813258, 39454542, 39454415, 39440615, 39421884, 39406784, 39256285, 39243449, 39154820, 39142532, 39136402, 39119745, 39118454, 38923850, 38912896 0 tubulointerstitial kidney disease, autosomal dominant, 2 0.7040398435219726
P48023 FASLG Tumor necrosis factor ligand superfamily member 6 Tier 1.5 0.76 1 A_surface 3 80.19 0 0     1 1 16581027 0 autoimmune lymphoproliferative syndrome type 1 0.6984292519156657
O14788 TNFSF11 Tumor necrosis factor ligand superfamily member 11 Tier 1 0.759 1 A_surface 2 79.19 0 0     1 2 15562003, 41226313 0 osteoporosis 0.6957850224892792
Q9BYF1 ACE2 Angiotensin-converting enzyme 2 Tier 1 0.758 1 A_surface 100 90.69 1 0     1 91 41716474, 41541792, 41274248, 40642289, 40333723, 40321580, 40227272, 39964138, 39923730, 39281706, 38973558, 38553521, 37932762, 37808754, 37692001, 37666993, 37385465, 37375202, 36950312, 36822303, 36714461, 36683236, 36581924, 36073793, 35972202, 35910791, 35907639, 35542182, 34876524, 34855379, 34847324, 34798263, 34696413, 34619249, 34458322, 34282416, 34248841, 34230708, 34230707, 34166652, 34123223, 33684258, 33683787, 33629859, 33561300, 33389440, 32981365, 32838280, 32551560, 36288301, 36170362, 35748608, 34953639 0 COVID-19 0.6925739512122528
P15391 CD19 B-lymphocyte antigen CD19 Tier 1.5 0.755 1 A_surface 4 62.22 1 0     1 13 41079126, 40652441, 38661725, 38148412, 36095289, 35829681, 34680368, 34364920, 32401486, 31912987, 29928472, 21127492 0 immunodeficiency, common variable, 3 0.6821072538733047
P32970 CD70 CD70 antigen Tier 1.5 0.75 1 A_surface 1 83.19 0 0     1 1 30609550 0 severe combined immunodeficiency due to CD70 deficiency 0.6651491980619259
Q96RJ3 TNFRSF13C Tumor necrosis factor receptor superfamily member 13C Tier 1.5 0.748 1 A_surface 8 63.03 1 0     1 1 23470998 0 immunodeficiency, common variable, 4 0.660711678987284
Q9HCK4 ROBO2 Roundabout homolog 2 Tier 1.5 0.744 1 A_surface 6 67.38 0 0     1 2 40616090, 31640794 0 familial vesicoureteral reflux 0.6460375744556555
P48551 IFNAR2 Interferon alpha/beta receptor 2 Tier 1 0.743 1 A_surface 9 64.44 0 0     1 1 35212764 0 COVID-19 0.6417504201511338
P21554 CNR1 Cannabinoid receptor 1 Tier 1 0.741 1 A_surface 32 71.69 1 0     1 1 19231809 0 obesity 0.6357831368051927
Q15116 PDCD1 Programmed cell death protein 1 Tier 1 0.738 1 A_surface 37 74.12 0 0     1 27 41479885, 40811947, 40758411, 39562585, 37424077, 34156677, 33904236, 33896107, 33319876, 33155587, 32574155, 32429721, 31727249, 31434881, 28912094, 28288993, 41907643, 41125194, 38158454, 37944524, 36484532, 36015348, 34861397, 34386332 0 melanoma 0.6260691959208758
Q8NER1 TRPV1 Transient receptor potential cation channel subfamily V member 1 Tier 1.5 0.738 1 A_surface 8 71.94 1 0     1 2 40855286, 28604222 0 migraine disorder 0.6269329225883602
P04233 CD74 HLA class II histocompatibility antigen gamma chain Tier 1 0.737 1 A_surface 24 69.94 1 0     1 1 30899255 0 non-small cell lung carcinoma 0.6217636836935354
P42658 DPP6 A-type potassium channel modulatory protein DPP6 Tier 1.5 0.737 1 A_surface 8 86.69 1 0     1 1 41313574 0 Autosomal dominant microcephaly 0.6225938492787458

Next page

Advanced export

JSON shape: default, array, newline-delimited

CSV options:

CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
 -- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
 -- Transparent weights over harvested evidence: structure 0.35, disease importance
 -- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
 -- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
 -- are predictions/detections, NOT measured EV-surface exposure.
 ROUND(
   0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
              WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
 + 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
 + 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
 + 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
 , 3) AS evidence_priority,
 (CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
 sc.surface_class,
 f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
 f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
 f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
 f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;
Powered by Datasette · Queries took 1554.602ms · Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target